Medications

Safety, efficacy of vadadustat explored for CKD

(HealthDay)—Vadadustat met the noninferiority criteria for cardiovascular safety versus darbepoetin alfa among patients with dialysis-dependent chronic kidney disease (DD-CKD), but not those with non-DD-CKD (NDD-CKD), according ...

Medical research

Drop-to-drop variation seen with fingerprick blood

(HealthDay)—There is drop-to-drop variation in blood component measures from fingerprick blood that is greater than variation in drops of venous blood, according to a study published recently in the American Journal of ...

Medical research

Blood test results vary from drop to drop in fingerprick tests

When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, ...

Diseases, Conditions, Syndromes

Screening performance differs with distinct fecal test brands

(HealthDay)—Different brands of fecal immunochemical tests (FITs) with the same cutoff hemoglobin concentration perform differently in detection of colorectal cancer (CRC), according to a study published in the December ...

Oncology & Cancer

Factors ID'd for CRC risk stratification with positive FIT

(HealthDay)—Fecal hemoglobin concentration, sex, and age can be used to classify the risk of advanced colorectal neoplasia among individuals with positive results from fecal immunochemical tests (FITs), according to a study ...

Diseases, Conditions, Syndromes

Study examines neurological outcomes for TBI treatments

In patients with a traumatic brain injury (TBI), neither the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin concentration through blood transfusion resulted in improved neurological ...

Diseases, Conditions, Syndromes

Restrictive transfusion strategy safe for acute GI bleeding

(HealthDay)—For patients with severe acute gastrointestinal bleeding, a restrictive transfusion approach is safe and effective compared with a liberal approach, according to a study published in the Jan. 2 issue of the ...

Medications

No evidence that doping enhances athletic performance

(HealthDay)—Although use of recombinant human erythropoietin (rHuEPO) is prohibited among athletes because it reportedly enhances performance, there is no scientific evidence that it does so, according to a study published ...

page 1 from 2